All data are based on the daily closing price as of July 22, 2024
g

Grape King Bio

1707.TW
4.41 USD
-0.05
-1.12%

Overview

Last close
4.41 usd
Market cap
652.70M usd
52 week high
6.16 usd
52 week low
4.41 usd
Target price
5.05 usd

Valuation

P/E
15.2763
Forward P/E
17.3611
Price/Sales
2.2146
Price/Book Value
2.3605
Enterprise Value
577.86M usd
EV/Revenue
1.7655
EV/EBITDA
6.0126

Key financials

Revenue TTM
328.15M usd
Gross Profit TTM
258.60M usd
EBITDA TTM
86.84M usd
Earnings per Share
0.29 usd
Dividend
N/A usd
Total assets
488.41M usd
Net debt
N/A usd

About

Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distribution; and Original Design Manufacturer/Original Equipment Manufacturer segments. The company offers Chinese herbal, probiotics, energy drinks, and health food supplements for gastrointestinal health, immunity regulation, weight control, liver care, brain health, eye care, feminine health, and sensual health care. It also provides functional ingredients, microbial fermentation, and food inspection services. Grape King Bio Ltd was founded in 1969 and is headquartered in Taoyuan City, Taiwan.
  • Symbol
    1707.TW
  • Exchange
    TW
  • Isin
    TW0001707008
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Bing-Jyun Cuei
  • Headquarter
    Taoyuan City
  • Web site
    https://www.grapeking.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top